Ayushman Bharat anchors India's global-health push
A government backgrounder pulls the whole Ayushman Bharat architecture into one frame and sets it against India's standing as the "pharmacy of the world".
What happened
- A Press Information Bureau backgrounder consolidated India's public-health architecture, tying domestic delivery to India's global pharmaceutical and bioeconomy weight.
- It restates Ayushman Bharat as an umbrella with four distinct components — PM-JAY, Ayushman Arogya Mandirs, PM-ABHIM and the Ayushman Bharat Digital Mission — each addressing a different layer of the health system.
- It logs current operational numbers: 434 million-plus Ayushman cards, 1,84,235 Ayushman Arogya Mandirs (as on 27 February 2026), and 863 million-plus ABHA digital health IDs.
- It situates the recently launched HPV Vaccination Programme (28 February 2026) — free single-dose Gardasil-4 for girls aged 14 — within this larger preventive-care effort.
- On the external side, it positions India as the world's third-largest pharmaceutical producer by volume and tracks a bioeconomy that grew from roughly $10 billion in 2014 to $165.7 billion in 2024, with a $300 billion target by 2030.
Background & context
Ayushman Bharat was announced in the 2018 Union Budget as India's move toward universal health coverage, replacing a fragmented model in which a thin Rashtriya Swasthya Bima Yojana sat above largely under-funded primary facilities. The design insight was that assurance and access have to be built together: an insurance card is of little use without a functioning clinic to walk into, and a clinic is of limited reach without a referral pathway and a financial backstop for costly hospital care. Ayushman Bharat therefore stitches four programmes into a continuum running from the village wellness centre up to tertiary hospital admission, with a digital spine threaded through all of it.
The nodal authority for the flagship insurance arm is the National Health Authority (NHA), which administers PM-JAY and the Ayushman Bharat Digital Mission, working through State Health Agencies. The Ministry of Health and Family Welfare is the parent ministry, and several components are centrally sponsored — funded jointly by the Union and the States in a fixed ratio rather than wholly from the central exchequer, which is what a central-sector scheme would be. This Centre–State cost-sharing is why coverage and packages can vary somewhat across States, and why some States run their own top-up assurance alongside PM-JAY.
The backgrounder's second axis — the "pharmacy of the world" framing — connects this domestic delivery story to India's external standing. India does not merely consume health goods; it supplies a large share of the world's affordable medicine and vaccines, which gives its health diplomacy real heft. The piece reads the two together: a country that can immunise tens of millions of its own newborns each year and simultaneously supply more than half of UNICEF's vaccine procurement is making a single argument about scale.
It helps to place each component in its lineage. The Ayushman Arogya Mandirs are the renamed Health and Wellness Centres first conceived under the National Health Mission, so the primary-care layer predates the Ayushman Bharat label and was folded into it. PM-JAY's predecessor logic runs back through the Rashtriya Swasthya Bima Yojana, which offered a far thinner ₹30,000 hospitalisation cover to below-poverty-line families; PM-JAY widened both the cover (to ₹5 lakh) and the eligible base (drawing on socio-economic census deprivation criteria rather than a simple BPL list). PM-ABHIM, by contrast, has no insurance role at all — it is a one-time infrastructure push, the supply-side complement to PM-JAY's demand-side financing. Read as a family, the four pieces map onto the standard health-system functions: financing (PM-JAY), service delivery at the base (AAMs), capital and surveillance capacity (PM-ABHIM), and information systems (ABDM).
Set against a peer, the contrast is instructive. Thailand's celebrated Universal Coverage Scheme reaches near-total population coverage through a tax-funded model with strong gatekeeping primary care. India's design reaches a comparable headline scale on the assurance side but layers a hospital-assurance card on top of a primary-care network that is still being built out, which is why the AAM and PM-ABHIM numbers matter as much as the PM-JAY card count — the system is only as strong as its weakest layer, and the financing arm has historically run ahead of the delivery arm.
For Prelims
- Ayushman Bharat = umbrella, four components: (1) PM-JAY, (2) Ayushman Arogya Mandirs, (3) PM-ABHIM, (4) Ayushman Bharat Digital Mission. Memorise the set — "how many components" and "match the pair" questions live here.
- AB-PM-JAY (Pradhan Mantri Jan Arogya Yojana): launched 23 September 2018; the world's largest publicly funded health assurance scheme; ₹5 lakh per family per year cover for secondary and tertiary care; 434 million-plus Ayushman cards issued; now extended to cover all senior citizens aged 70 and above regardless of income; ₹9,500 crore in Budget Estimates 2026-27.
- Ayushman Arogya Mandirs (AAMs): the rebranded Health and Wellness Centres delivering comprehensive primary care; 1,84,235 operational as on 27 February 2026; over 426.6 million teleconsultations delivered. This is the primary-care floor of the architecture.
- PM-ABHIM (Pradhan Mantri Ayushman Bharat Health Infrastructure Mission): launched 2021; outlay ₹32,928.82 crore over 2021-22 to 2025-26; builds district and block-level public-health infrastructure — labs, critical-care blocks, surveillance capacity.
- Ayushman Bharat Digital Mission (ABDM): the digital backbone; 863 million-plus ABHA (Ayushman Bharat Health Account) IDs created as on 27 February 2026 — a unique health ID linking a citizen's records.
- HPV Vaccination Programme (launched 28 February 2026): free single-dose Gardasil-4 for girls aged 14; protects against HPV types 16, 18, 6 and 11; roughly 11.5 million girls eligible; India joins 160-plus countries with national HPV programmes — a cervical-cancer prevention measure.
- Wider immunisation set: Universal Immunisation Programme (11 vaccines; ~26.7 million newborns reached yearly); Mission Indradhanush (launched 25 December 2014, catch-up immunisation); plus Tele MANAS (mental-health tele-service, 10 October 2022) and i-DRONE (drone vaccine delivery, 2021).
- Pharmacy of the world: India is the third-largest pharma producer by volume; supplies about 20% of global generics, 55–60% of UNICEF vaccines, and over 70% of global anti-retrovirals (HIV medication).
- Bioeconomy: ~$10 billion (2014) → $165.7 billion (2024), with a $300 billion target by 2030; Budget 2026-27 launched Biopharma SHAKTI; the earlier National Biopharma Mission "Innovate in India (i3)" (2017) is run through BIRAC.
- Affordable-medicine arm: PMBJP (Pradhan Mantri Bhartiya Janaushadhi Pariyojana) runs 17,990 Janaushadhi Kendras selling generics 50–90% cheaper; the SAHI strategy on AI in healthcare was launched in February 2026.
Why it matters
The structural problem Ayushman Bharat addresses is catastrophic health spending. Out-of-pocket expenditure has historically been the dominant share of India's health financing, pushing millions of households below the poverty line each year after a single hospital admission. By offering a ₹5 lakh assurance to the bottom of the income distribution — and then extending it to every senior citizen above 70, a group with rising care needs and falling earning capacity — PM-JAY is meant to break that impoverishment cycle. The 70-plus extension is significant because it makes eligibility age-based rather than purely poverty-based, widening the social base of the scheme.
The second significance is the layering. A country cannot leap straight to hospital insurance and skip primary care; that simply funnels avoidable cases into expensive tertiary beds. By pairing PM-JAY with 1.84 lakh Ayushman Arogya Mandirs and a district-infrastructure mission in PM-ABHIM, the architecture tries to catch disease earlier and cheaper, while the digital mission reduces duplication and leakage through verifiable health IDs. The external dimension matters for India's diplomacy and supply-chain resilience: being the world's vaccine and generics supplier converts public-health capacity into strategic weight, visible in vaccine maitri and in pricing leverage over global drug markets.
For Mains
Related: Ayushman Bharat hub · Schemes & Welfare · This week's cards